Even if assays on functional activity of the CFTR were not included in the present study, our results could provide a proof-of-principle that miRNA masking might represent an efficient tool to increase CFTR content (possibly by increasing CFTR stability), with possible applications in the personalized therapy of CF. Here, CFTR is linked to cystic fibrosis.